Paolo Sfriso - Concepedia

Author

Paolo Sfriso

Also Known As

Andrea Taddio, Angelo Ravelli, Antonella Insalaco, Lo Nigro A, P Sfriso, P. SFRISO, P. Sfriso, Paolo Sfriso, Peruzzo L, Sfriso P

287

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

University of Padua University of Siena University of Bari Aldo Moro Istituti di Ricovero e Cura a Carattere Scientifico University of Florence

About

Paolo Sfriso is an author at University of Padua specializing in medicine, rheumatology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	24	984
2	Public Health	3	3	213
3	Allergy	3	3	64
4	Health Sciences	1	1	85
5	Natural Sciences	1	1	31

Paolo Sfriso

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis Jurgen Sota, Antonella Insalaco, Rolando Cimaz, Frontiers in Pharmacology	2019	616
IL-32, a Novel Proinflammatory Cytokine in Chronic Obstructive Pulmonary Disease Fiorella Calabrese, Simonetta Baraldo, Erica Bazzan, American Journal of Respiratory and Critical Care Medicine	2008	171
SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients Margherita Zen, Enrico Fuzzi, D. Astorri, Journal of Autoimmunity Autoimmune DiseaseSars-cov-2 InfectionRheumatic DiseasesImmunologyNortheast Italy	2020	110
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients Paolo Sfriso, Roberta Priori, Guido Valesini, Clinical Rheumatology AgingDisease ProgressionGeriatricsMedicineSymptomatic Treatment	2016	104
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study Serena Colafrancesco, Roberta Priori, Guido Valesini, Frontiers in Pharmacology	2017	104
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study Antonio Vitale, Antonella Insalaco, Paolo Sfriso, Frontiers in Pharmacology	2016	87
Effects of mud-bath treatment on fibromyalgia patients: a randomized clinical trial Antonella Fioravanti, G Perpignano, G Tirri, Rheumatology International Randomized Clinical TrialPain DisordersInterventional Pain MedicinePain MedicineRehabilitation	2007	85
The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: Clinical manifestations and long-term follow-up Luca Cantarini, Donato Rigante, Giampaolo Merlini, Seminars in Arthritis and Rheumatism InflammationRheumatologyRecurrent Inflammatory AttacksLong-term Follow-upAutoimmune Disease	2013	81
A comparative study of serum and synovial fluid lipoprotein levels in patients with various arthritides Francesca Oliviero, Alessandro Lo Nigro, D. Bernardi, Clinica Chimica Acta InflammationRheumatoid DisorderOsteoarthritisComparative StudyVarious Arthritides	2011	78
Effects of half dose etanercept (25 mg once a week) on clinical remission and radiographic progression in patients with rheumatoid arthritis in clinical remission achieved with standard dose. Bernd Raffeiner, Costantino Botsios, Francesca Ometto, PubMed	2015	74

Page 1